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The intraperitoneal (i.p.) injection of mineral oil or the pure alkane, pristane 
(2,6,10,14-tetramethylpentadecane), induces the formation of a  granulomatous 
tissue on the mesentery, diaphragm, omentum, and other peritoneal connective 
tissues that is composed predominantly of phagocytic cells which have ingested 
oil  and  adhered  to  these  surfaces.  The  granuloma  is  vascularized  and  also 
contains lymphocytes, granulocytes, and plasma cells (1). 
In BALB/c mice, the i.p. injection of mineral oil or pristane induces a high incidence of 
plasmacytomas (PCT)  1 that arise i.p. in close association with the granuloma evoked by 
the oil. Most primary PCT cells fail to grow when transplanted to the peritoneal cavity of 
normal, syngeneic mice at doses of 105 cells or less (2). Successful transplantation of all 
primary PCTs may be obtained, however, by conditioning the recipient mice with an i.p. 
injection ofpristane 30-60 days before tumor cell inoculation (2). This fmding, in addition 
to the  close association of primary PCTs with the  oil  granuloma,  suggests  that  the 
primary PCT is dependent upon microenvironmental factors provided by the granuloma 
during early stages  of tumor development. The dependence of primary PCTs on the 
pristane-conditioned environment is transient,  and most tumors acquire the ability to 
grow in the normal peritoneum after several transplant generations. Since the granu- 
loma is composed largely of macrophages and polymorphonuclear leukocytes (PMNL) 
which have ingested oil, the possibility that these cells facilitate the growth of primary 
PCTs must be considered. 
Other independent studies indicate that adherent cells influence the growth of PCT 
cells. Namba and Hanaoka (3) found that the adaptation of the PCT MOPC 104E to long 
term tissue culture requires the presence of adherent cells or adherent cell products. In 
further studies they isolated a factor from a normal phagocytic cell line that overcomes a 
block in the G1 stage of the cell cycle of MOPC 104E cells grown in vitro (4). Metcalf (5) 
described a serum factor that promotes soft agar colony formation by PCT cells obtained 
directly from established in vivo cell lines. The i.p. injection of mineral oil increased this 
activity in the serum. Thus, findings to date support the notion that adherent cells are a 
source of factors which promote PCT growth in vitro. The relation of these effects to the 
environment produced by the pristane-induced granuloma in vivo is less clear. Accord- 
ingly, we have extended our previous study in order to clarify the role of the adherent 
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peritoneal cell  (APC) population and the APC  granuloma  in promoting primary PCT 
growth in vivo. 
Takakura  et al. (6) observed that hydrocortisone (HC) administration  reduced 
both granuloma  formation  and  PCT  development  in mineral  oil-treated mice. 
Thompson  and VanFurth  (7) demonstrated  that HC prevented the migration  of 
mononuclear  cells into the  inflamed  peritoneal  cavity,  but did not reduce  the 
existing population of peritoneal macrophages.  Studies with HC and parameth- 
asone  indicate  that  these  drugs  have  similar  effects  upon  the  PMNL  compo- 
nent  of inflammatory  exudates  (8,  9),  although  the elevation of the numbers  of 
these cells in the circulation was not prevented. These results suggest that if the 
pristane-induced  APC  are critical for the  establishment  of a  conditioned envi- 
ronment,  then  HC  treatment  should  abrogate  the  conditioning effect.  Conse- 
quently,  we have  studied the effects of HC  on the pristane-conditioning  effect. 
Additionally,  we have  examined  the  conditioning capabilities of thioglycolate 
medium  (TGM),  an  agent  that  produces an  elevation of the  free APC  popula- 
tion, but does not result in granuloma  formation. We have also tested the ability 
of passively transferred,  TGM-induced APC to restore conditioned environment 
production in mice treated  with pristane  and HC  simultaneously. 
Materials  and  Methods 
Mice.  BALB/c AnN  mice,  6-8 wk  of age,  weighing approximately 20  g,  were  used in all 
studies. Mice were obtained from the National Institutes of Health Breeding Colony, Bethesda, 
Md. 
Drugs and Chemicals.  Pristane (2,6,10,14-tetramethylpentadecane) was obtained from Ald- 
rich Chemical Co.  Inc.,  Milwaukee, Wis., and injected i.p.  using 25G  ×  1/2 inch needles. HC 
(Cortef acetate, Upjohn Co., Kalamazoo, Mich.) was injected subcutaneously at a dosage of 0.5 mg 
per mouse in the regimens indicated. Sterile liquid TGM  (Difco  Laboratories, Detroit, Mich., 
0.29% in water) was injected i.p. at a dosage of 0.5 ml in the regimens indicated. Eagle's minimum 
essential medium (MEM), Hanks' balanced salt solution (BBS), fetal calf  serum (FCS), and trypan 
blue dye were obtained from Grand Island Biological Company, Grand Island, N.Y. Extra high 
amino acids medium (EHAAM) (10) was obtained from the National Institutes of Health Media 
Unit, Bethesda, Md.  2-Mercaptoethanol was obtained from Eastman Organic Chemicals, Div., 
Eastman Kodak Co., Rochester, N. Y. [3H]thymidine in sterile aqueous solution, at i mCi/ml, was 
obtained from Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y. 
Primary Ascitic Tumor Cells for In Vivo Transplantation.  PCTs were induced in BALB/c mice 
through multiple injections ofpristane as previously described (11). Ascitic fluid was drained from 
the primary host using a 16G x 11/2 inch hypodermic needle and maintained in an ice bath. Viable 
cell counts were performed using the exclusion of an 0.4% solution of trypan blue dye as the 
criterion for viability. The ascites were diluted with BSS to produce a density of 2 × 105 or 2 × 104 
viable cells per ml, and 0.5 ml of this suspension was administered to recipient mice. 
Fixed Tissue Sections.  Tissues were removed from animals and fixed for 24 h  in Fekete's 
modification of Tellesznicky's solution. The sections were then  cut and stored in 70% ethanol 
before embedding, sectioning, and staining with hematoxylin-eosin. 
Scoring of Tumor Growth.  Mice were screened at 5-day intervals for successful PCT trans- 
plantation by the examination of a  Wright's stained smear of peritoneal fluid. The presence of 
numerous large, hyperchromatic PCT cells, characteristic of PCTs, was the criterion for a positive 
smear. This method afforded an accurate method for the early detection of progressively growing 
tumors. 
Peritoneal  Cell  Counts.  Mice were  sacrificed by cervical dislocation. The peritoneum was 
opened and the contents everted in 30 ml of calcium-magnesium-free BSS. The resulting suspen- 
sion was centrifuged for 5 rain at 3,000g, and the pellet was resuspended in 5 ml of MEM made 10% 
with FCS. Total cell counts were immediately  performed in a hemacytometer. Smears for differen- 
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smear preparation. These smears were air dried and later stained with Wright's stain and counted 
under 430 or 1,000 x  magnification. Percentages were calculated from counts of at least 200 cells. 
The remaining suspension was transferred to 60-mm plastic tissue culture dishes (Falcon Plastics, 
Oxnard, Calif.) and incubated at 37°C in a humidified atmosphere of 5% COs in air for 1 h. After 
gentle agitation, the nonadherent cells were decanted and counted. The adherent cell count was 
calculated as the total cell count less the nonadherent count. In some experiments, the adherent 
cells  remaining  in  the  tissue  culture  dishes  were  also  stained  and  differential  counts  were 
performed. 
TGM-Induced APC for Cell Transfer Experiments.  Donor mice were treated i.p. with 0.5 ml of 
TGM. After 5-7 days, the mice were sacrificed by cervical dislocation, and the peritoneal wall was 
exposed. A 5-ml aliquot of BSS was injected i.p. and then withdrawn with a 16G ×  11/2 inch needle. 
The resulting cell suspension was delivered to a 50-ml centrifuge tube and maintained on ice. The 
washings of 10 mice were pooled and centrifuged in the cold at 1,800 g  for 10 min. The pellet was 
resuspended in 25 ml of MEM made 10% with FCS, placed in 100-mm plastic tissue culture dishes 
(Falcon Plastics),  and incubated for  1  h.  The nonadherent cells were withdrawn after gentle 
agitation.  The adherent cells were scraped from the dish with a  sterile rubber policeman and 
resuspended in 5 ml of BSS. The density was adjusted to 4 x  10  ~ viable cells per mt, and 0.5 ml was 
injected i.p.  in recipient mice. 
Results 
Rapid Conditioning  of the Peritoneal Environment.  In previously reported 
studies (2), conditioning was established by injecting 0.5 ml of pristane 30-60 
days before the transplantation of primary PCT cells. In the present experi- 
ments, pristane was administered 3, 14, and 30 days before transplantation. The 
two PCTs tested failed to grow in untreated control groups by day 100, but 
developed rapidly in all three of the pristane-treated groups (Table 1). The 3-day 
conditioning period appeared more efficient when the latent periods of these 
groups were compared by a Mann-Whitney U test, but additional experiments 
would be required to establish this as a general rule. These findings indicated 
the feasibility of a 3-day conditioning period and facilitated experiments on the 
effects of HC. 
Changes  in the Free Peritoneal Population  After Pristane Conditioning  and 
HC Treatment.  Total cell counts were performed as described in three groups: 
(a) pristane-treated mice, (b) mice given 0.5 mg of HC daily beginning simulta- 
neously with pristane injection, and (c) mice given 0.5 mg of HC daily beginning 
3 days after pristane injection (HC-lag group). The proportion of adherent to 
nonadherent cells was established by determining the number of cells which 
adhered to a plastic tissue culture dish after 1 h of incubation. 
Within 3 days after pristane injection, the free peritoneal cell population rose 
from a  normal value of 1.55  ×  106 to 4.10  x  106. After 7 days, an additional 
increase to a level of 5.28 × 106 had occurred. Thereafter, the total cell popula- 
tion remained relatively constant until day 50 (Table II, Fig. 1). The adherent, 
mononuclear cell population was the primary source of this increase, as the 
nonadherent cell counts did not deviate significantly from the normal value 
during this period, and the proportion of mononuclear cells in the peritoneal 
population rose from 35 to greater than 50%  (Table II).  Although the relative 
proportion of PMNL decreased over this period, the actual numbers increased. 
Moreover, these cells contributed noticeably to the adherent cell population in 
pristane-treated mice (Table HI).  Generally, the adherent cell population ap- 
peared  to  reflect the  combined mononuclear and PMNL  components of the 
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TABLE  ] 
Transplantation of Primary Plasmacytoma Cells in Mice Treated with Pristane at 
Varying Intervals Before Tumor Inoculation 
Days  of pris-  Day  PCT  Proportion 
tane  exposure  dead  at  100  Average  day  of 
Tumor  cells  first 
before  inoc-  detected  days  postinocu-  death  and  range 
ulation  lation 
FLOPC  4  0  -  0/10  - 
3  25  10/10  42  (35-50) 
14  40  10/10  58  (50-66) 
30  40  10/10  60  (50-70) 
MUTIV  no.  20  0  -  0/10  - 
3  30  10/10  47  (40-60) 
14  25  i0/10  66  (52-70) 
30  25  10/10  64  (54-78) 
Mice  were  injected  i.p.  with  0.5  ml  of pristane  3,  14,  or  30  days  before  receiving  105  cells  of the 
indicated  primary  plasmacytoma.  Mice  were  observed  for tumor  growth  as described  in the  text. 
Control  mice  received  tumor  cells  only. 
TABLE  II 
Changes in the Free Peritoneal Cell Population After Pristane and HC Treatment 
Day 
0 
3 
7 
10 
20 
30 
40 
50 
Pristane 
Total cells  Nonadherent 
x  l0  s  ×  l0  s 
1.55  ±  0.06  a  1.12 ±  0.06  a 
4.10 _+ 0.12  b  1.15 ± 0.08  a 
5.28 ±  0.08  c  1.23 ±  0.06  a 
5.10 ±  0.0b  ~"  1.24 ±  0.05  n 
5.20 ±  0.0~  1.27 ±  0.13  a 
5.10 ±  0.I0  c  1.40 ~  0.06  a 
4.93 +  0.06  c  2.87 ±  0.09  b 
5.82 ±  0.42  d  3.20 ~ 0.08  b 
Differential counts 
Mono-  Lympho- 
PMNL 
cytes  cytes 
%  %  % 
36 ±  1.2  35  ±  0.6  29 ±  0,6 
24 ±  1.5  i 49±  1.5  23 ~  2.0 
22 -~ 1.5  54 _+ 1.2  24 ±  1.8 
24 ±  1.5  54 _+ 1.2  22 ±  2.1 
25 ±  1.2  52 ±  2.2  22 -+ 2.6 
27 ±  0.6  53 _+ 4.5  19 ±  0.9 
38±0.9  35±  1.0  26±  1.91 
26±0.9  34-+  1.9  39-*  1.5 
Hydrecortiscne 
Differential counts 
Total cells  Nonadherent 
×  l0  s  x  10  ~ 
1.77  ±  0.15  1.05  ±  0.05 
1.73  ±  0.06  1.05 _+ 0.09 
1.85  •  0.13  1.13  ± 0.03 
1.70  ±  0.06  1.05 ±  0.05 
1.72  ~  0.09  1.13  _+ 0.07 
1,72  ±  0.09  1.05  _+ 0.08 
1,82  ~  0.04  1.05  _+ 0.05 
Monoo  Lympho- 
PMNL 
cytes  cytes 
%  %  % 
30  ±  1.2  24_+  1.2  46±2.3 
36  -+ 4.3  14  ±  6.2  50  -+ 2.5 
24  -+  1.8  14  ±  2.0  62  ±  3.8 
29  ±  2.1  17  ±  2.1  54  ±  1.2 
19 ±  4.6  18 ±  2.3  63  ±  2.9 
17 -+ 3.5  19 ±  1.8  64 -* 3.7 
! 25  ±  3.1  15 ±  2.3  60 -~ 5.0 
Cell counts were performed as described in the text on three groups: (a) mice treated with  ~ristane  alone; (b) mice treated with pristane and 
concomitantly  placed upon a  regimen of 0.5 mg HC daily.  Each entry is mean  ±  SE of three  mice. One-way analysis of variance was 
performed  on  each  set  of counts  and,  where  significant differences were  found  at  the  5%  level,  Student  Neurnan-Kuels  tests  were 
performed. Superscripts indicate the groups delineated  by this test.  Differential cell counts were performed on Wright's stained smears 
prepared from peritoneal  cell  samples. The percentages are calculated  from the mean counts of three mice. Each count consisted of at 
least 200 cells. 
Continuous HC treatment beginning simultaneously with pristane injection 
prevented any change in the total free peritoneal cell population, although there 
was a depression in the proportion of mononuclear cells and an increase in the 
proportion of lymphocytes (Table II, Fig. 1). In the HC-lag group, the normal 
and 3-day values agreed well with those of the pristane-treated group. Further, 
the total peritoneal cell count did not decrease after the onset of  HC treatment in 
this group, but remained substantially higher than the normal value through 
day 30. As in the pristane-treated group, the adherent cells were the predomi- 
nant source of this increase (Fig. 2). 
Interestingly, by day 50 there was an additional increase in the total perito- 
neal cell population ofpristane-conditioned  mice which appeared to be attributa- 
ble to the nonadherent cell population (Table II, Fig. 1). 1558  ATTACHED  MACROPHAGES  PROMOTE  PLASMACYTOMA  GROWTH 
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FIG.  1.  Mice were sacrificed at intervals aider either pristane or pristane-HC treatment, 
and the peritoneal contents were washed in 30 ml of calcium-magnesium-free  Hanks' BSS. 
The resulting suspension was centrifuged at 3,000g for 5 rain and the pellet resuspended in 
Eagle's MEM.  Total  cell  counts were  performed immediately,  and  the  remaining cell 
suspension transferred to  60-mm plastic tissue culture  dishes and  incubated  1  h.  The 
nonadherent cells were decanted and counted. Each point is the mean _+  SE of counts on 
three mice. 
TABLE  III 
Differential Adherent Peritoneal Cell Counts in Pristane- and TGM-Treated Mice 
Pristane  Repeated thioglycolate 
Days after 
irritant in- 
jection  PMNL  Monocytes  Lympho-  PMNL  Monocytes  Lympho- 
cytes  cytes 
%  %  %  %  %  % 
0  47  48  5 
3  40  59  1  45  48  8 
7  36  63  1  35  60  6 
10  46  47  7  21  75  4 
30  49  49  2  -  -  - 
Differential cell counts were performed on plates of adherent peritoneal exudate cells that were 
directly Wright's stained. The percentages are calculated from the mean counts of three plates. 
Each count consisted of at least 200 cells. 
Granuloma Formation in Pristane- and HC-Treated Mice.  Granuloma for- 
mation was followed in groups of mice treated identically as those in the cell 
count experiments by the examination of fixed tissue sections of the peritoneal 
mesentery. In pristane-treated mice, the onset of granuloma formation was 
apparent as early as 3 days after pristane injection (Fig.  3).  The granuloma 
became progressively larger through day 30, and contained numerous droplets 
of entrapped oil (Fig. 3). In mice that received HC treatment beginning simulta- MICHAEL  CANCRO  AND  MICHAEL  POTTER 
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neously with pristane injection, however, minimal granuloma formation was 
observed during this period. In the HC-lag group, however, granuloma forma- 
tion closely paralleled that of the group given pristane alone. 
The Effect of HC Treatment on Pristane Conditioning.  The effect of HC on 
pristane conditioning was examined with eight different primary PCTs (Table 
IV). Either 104 or 10  ~ primary PCT cells were injected i.p. in four groups of 10 
mice each.  Control mice  (Group I) received no previous treatment; Group II 
received pristane 3 days before tumor inoculation; Group HI received pristane 3 
days before tumor inoculation and were simultaneously placed upon daily HC 
treatment; and Group IV was conditioned with pristane 3 days before transplan- 
tation and placed upon HC treatment on the day of  transplantation (HC-lag). 
All of the primary PCTs were dependent upon the pristane-conditioned envi- 
ronment for growth. Only one of the 120 inoculated mice developed a  tumor, 
whereas all of the pristane-conditioned mice developed progressively growing 
tumors. In contrast, only 26 of the 120 mice treated with HC beginning simulta- 
neously with pristane injection developed tumors. Groups that were exposed to 
pristane for 3 days before beginning HC treatment, however, closely paralleled 
the groups receiving pristane alone, indicating that the lack of tumor growth in 
Group III was not due to toxic effects of HC. All primary PCTs assayed to date 
have produced similar results (Table IV). 
The Inability of TGM to Produce a Conditioned Environment.  A single i.p. 
injection of TGM produced a brief elevation of the free peritoneal cell population 
FIG.  2.  Cell counts were performed as described in Fig. 1 on groups of mice treated with 
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TABI~  IV 
Summary of Tumors Tested in Pristane-Conditioned and Hydrocortisone-Treated Mice 
Number of mice in 
Cells  group dead at 100 days 
Tumor  inoc. 
log 10  CON  PRIS  HC  LAG 
I  II  111  IV 
TEPC604  5  0  10  4  i0 
TEPC604  4  0  10  3  tO 
MOPC702  5  0  10  2  - 
MOPC702  4  0  10  2  - 
PC55  5  0  10  2  10 
PC55  4  0  10  2  10 
PC8  5  0  10  2  10 
PC8  4  0  I0  1  10 
NIPC21  5  1  10  2  10 
NIPC22  5  0  10  2  - 
DMBA16  5  0  10  1  10 
TEPC828  5  0  10  3  10 
Average day of death and range 
CON  PRIS  HC  LAG 
1  ll  III  IV 
-  55 (50-70)  70 (65-80)  60 (58-70) 
--  60 (55-75)  80 (75-90)  62 (50-70) 
-  50 (40-65)  80 (70-90)  - 
52 (45-60)  85 (70-100)  - 
-  50 (40-6,5)  72 (65-80)  60 (40-75) 
-  75 (70-85)  70 (65-75)  80 (70-95) 
-  55 (45-65)  75 (70-80)  60 (45-70) 
-  70 (65-85)  92 (85-100)  80 (70-90) 
80  40 (35-40)  50 (45-55)  45 (40-60) 
-  45 (35-40)  60 (55-65)  - 
-  55 (45-60)  70  65 (55-70) 
-  63 (49-72)  77 (70-84)  68 (52-80) 
Average day of  positive smear and range 
CON  PRIS 
I  II 
45 (35-50) 
50 (40-60) 
40 (35-50) 
-  4O (35-50) 
-  50 (40-60) 
-  65 (55-70) 
45 (35-50) 
-  65 (65-70) 
65  30 (25-35) 
-  35 (30-40) 
-  40 (30-45) 
-  39 (31-52) 
HC 
III 
60 (50-70) 
75 (65-90) 
65 (60-70) 
70 (65-75) 
55 (65-60) 
60 (60) 
62 (50-70) 
80 (70-85) 
32 (25-40) 
45 (40-55) 
62 
47 (45-53) 
LAG 
IV 
50 (45-56) 
55 (50-65) 
45 (40-55) 
65 (50-90) 
42 (35-50) 
62 (55-80) 
35 (25-45) 
50 (45-60) 
45 (35-56) 
Primary tumor cells were inoculated  i.p. to four groups of recipient  mice: I. Control mice receiving cells only; II. pristane-treated  mice 
received 0.5 ml of pristane 3 days before tumor inoculation; III. HC.treated  mice received 0.5 ml of pristane and were placed upon 0.5 mg HC 
daily 3 days before tumor inoculation;  and IV, HC-lag received 0.5 ml of pristane 3 days before tumor inoculation  and were placed upon HC 
treatment concomitant  with tumor inoculation. 
which reached a  maximum value  of 3.5  ×  106 7 days  after injection (Fig.  4). 
When TGM was given repeatedly at 4-day intervals, a prolonged elevation of  the 
free peritoneal cell population similar to that obtained with pristane was seen. 
The total peritoneal cell population reached a maximum value of 6.55  ×  106 on 
day  10.  By day  20,  this number had decreased  to a  value  of 4.38  ×  10  ~ and 
remained at this level through day 30 (Fig. 4). Again, the adherent cell popula- 
tion was the primary source of this increase. The initial proportion of monocytic 
cells to PMNL in the TGM-induced APC population paralleled that obtained 
with pristane (Table HI). By day 10, however, there was a greater proportion of 
monocytic cells  in the TGM-treated mice.  In contrast to pristane treatment, 
however,  no  granuloma  formation  was  found  on  the  peritoneal  connective 
tissues by day 30. To determine whether granuloma formation was necessary for 
the conditioning effect, the ability of TGM treatment to produce  a conditioned 
environment was examined with six primary PCTs. Cells were injected i.p. in 
four groups of 10 mice each.  Control mice received no prior treatment; TGM- 
treated mice received 0.5 ml of TGM 3 days before tumor inoculation. Repeated 
TGM-treated mice received 0.5 ml of TGM i.p. every four days beginning 3 days 
before tumor inoculation.  A  group of pristane-treated mice was included as a 
positive control. 
The control and pristane-treated groups indicated that the PCTs used were 
dependent  upon  a  conditioned  environment for growth.  In  the TGM-treated 
groups, no PCT growth was observed (Table V). This finding suggested that the 
elevation  of the free APC  population  without granuloma  formation was not 
sufficient to produce a conditioned environment. 
Reconstitution of the Conditioning Effect in Pristane-HC-Treated Mice with 
Fro.  3.  Stages  of developing  granuloma  in  BALB/c  mice  after  pristane  treatment.  (a) 
Mesentery  3  days  after  pristane  injection,  140  x.  (b)  Mesentery  20  days  after  pristane 
injection.  Note  oil  droplets  entrapped  in  the  forming  granuloma,  88  x.  (C)  Mesentery  30 
days  after pristane  injection,  88  x.  All  sections  were  stained  with  hematoxylin-eosin. 1562  ATTACHED  MACROPHAGES  PROMOTE  PLASMACYTOMA  GROWTH 
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FIo. 4.  Cell  counts  were performed as described  in Fig. 1 on mice treated  with either  a 
single  injection  of  0.5 rnl of  TGM  i.p.,  or with 0.5 ml of  TGM  i.p.  repeatedly  at 4-day 
intervals. 
Passively Transferred TGM-Induced APC.  In three experiments of this type, 
three additional treatment groups were included. These consisted of a pristane- 
HC-treated group, an HC-lag group (as previously described), and a group that 
received  pristane,  simultaneous HC  treatment,  and  four  doses  of 2  ×  106 
syngeneic, TGM-induced adherent cells i.p. at 4-day intervals beginning 3 days 
before tumor inoculation. The purpose of these groups was twofold. First, they 
examined whether TGM-induced APC could provide a conditioned environment 
when stimulated to form a  granuloma by pristane.  Second, they provided a 
means of determining whether passively acquired APC would reconstitute the 
production of a conditioned environment in mice whose APC response to pris- 
tane was suppressed. 
In the groups receiving TGM-induced APC, 29 of the 30 mice tested exhibited 
successful transplantation (Table V). Further, sections of peritoneal mesentery 
revealed that  extensive granuloma formation had taken place.  In all  other 
groups, the results were consistent with previous experiments. 
Discussion 
An environment conducive to primary PCT growth is produced as few as 3 
days after the i.p. injection of pristane. This result extends previous observa- 
tions that 30-60 days of pristane exposure elicits this effect. Further, a condi- 
tioned environment is established simultaneously with the rapid influx and 
deposition of large  numbers of adherent cells  in the peritoneal cavity,  and 
suppression of this influx with HC abrogates conditioning. Since pristane is a MICHAEL  CANCRO  AND  MICHAEL  POTTER  1563 
TABLE V 
Summary of Transplantation Experiments  with TGM-Treated Recipients and Passively 
Transferred TGM-Induced APC 
Number of  mice in group of  i0 developing progressively  growing tumors by day i00 
Pristane 
Tumor  Untreated  Pristane  TGM  Repeated  Pristane  HC Lag  HC TGM 
TGM  HC 
cells 
CBPC  116  0  10  0  0  -  -  - 
TEPC  827  0  10  0  0  -  -  - 
TEPC  829  0  10  0  0  -  -  - 
TEPC  831  0  10  0  0  1  10  9 
TEPC  828  0  10  0  0  3  10  10 
CBPC  118  0  10  0  0  2  10  10 
Primary tumor cells  were inoculated i.p.  to  each group. The untreated, pristane,  pristane  HC, and 
HC lag  groups were identical  to  those in  Table IV. TGM-treated mice received TGM  3 days  before 
tumor inoculation.  Repeated TGM-treated mice received  TGM  at  4-day  intervals  beginning 3  days 
before tumor inoculation. Reconstituted mice received pristane, simultaneous HC  treatment, 
and four doses of 2 ×  106 TGM-induced APC at 4-day intervals  beginning 3 days before tumor 
inoculation. 
nonmetabolizable substance and is  not  cleared  from  the  peritoneal  cavity,  these 
results  indicate  that  pristane  in  the absence of  an  adherent  cell  population  does 
not produce a conditioning  effect.  This finding  strongly implicates  the APC 
population in the conditioning process.  Moreover, the transplantation data 
obtained  using  delayed HC treatment  shows  that  the  adherent  cell  influx  during 
the initial  3 clays  of  pristane  exposure is sufficient  to establish  a conditioned 
environment. These results,  in conjunction  with the peritoneal  cell  counts in 
this  group, indicate  that the pristane-induced  APC population may undergo a 
substantial  amount of  division  in  the peritoneum. These findings  are  consistent 
with those  of  Ryan and Spector (12,  13)  who showed that  granulomata induced 
by paraffin  oil,  incomplete Freund's adjuvant,  and  Bordetella pertussis  vaccine 
exhibit  high rates  of [3H]thymidine incorporation  compared to those induced 
with carrageenan. They attributed  this  differential  stimulation  of  macrophage 
mitogenesis  to  the relative  toxicity  of  the irritant  employed and  the availability 
of  newly recruited  mononuclear cells. 
Growth-stimulating  or  viability-enhancing  properties  have  been  attributed  to 
similar  situations  and cell  populations  both in vivo  and in vitro.  Namba and 
Hanaoka (3,  4)  described  a soluble,  nondialyzable  factor  elaborated  by cultured 
adherent cell  populations  which facilitates  the long term in  vitro  cultivation  of 
established  PCT cell  lines.  Metcalf (5) reported  that a factor  present in the 
serum  of  BALB/c mice  after  mineral  oil  injection  stimulated  colony  formation by 
cells  obtained from established  in vivo cell  lines.  VanDenBrenk  et al. (14) 
observed increased  lung colony-forming efficiency  of  the tumors Y-P388 and 
W256 when they were grown in an acutely  inflamed environment. 
The results  obtained herein using TGM-treated recipients,  however, show 
that elevation  of  the free  APC population alone is not sufficient  to produce a 
conditioning  effect,  and that  the establishment of  a resident  population  of  these 
cells  is a necessary event in the conditioning  process.  This interpretation  is 
supported by the results  of  the passively  transferred  APC experiments, where 1564  ATTACHED  MACROPHAGES  PROMOTE  PLASMACYTOMA  GROWTH 
TGM-induced APC are capable of conditioning if stimulated to form a granu- 
loma by pristane.  Additionally, these results confirm the role of APC in the 
conditioning effect in vivo. 
The requirement for granuloma formation in vivo may indicate that attached 
macrophages provide a substratum suitable for the adherence of primary PCT 
cells. The close association of primary PCTs with the granuloma in vivo (1) 
supports this possibility. Selective physical interactions between immunoglobu- 
lin-bearing lymphocytes and macrophages are well established (15-17),  and it 
would thus not be surprising if PCT cells also behaved in this fashion. 
The overall mechanism through which the APC granuloma influences pri- 
mary PCT growth in vivo might be rather complex. In addition to providing a 
suitable  substrate  for  cellular  adherence  and  proliferation,  soluble  growth- 
enhancing factors similar to those described in vitro (3-5) might also be elabo- 
rated. Systems to investigate this possibility are currently being developed in 
this laboratory. Preliminary results indicate that a soluble material produced by 
pristane-induced APC enhances the in vitro immunoglobulin production and 
microcolony formation by  primary  PCT  cells.  If soluble  APC  products  are 
involved in the conditioning process in vivo, however, the singular ability of 
granuloma-inducing materials to establish a  conditioned environment would 
suggest that such materials are secondary to the adherence phenomena. The 
close association of the PCT cells with the granuloma would, of course, insure 
the exposure of  the developing tumor to any stimulatory substances produced by 
the APC. Further, the observations that macrophages stimulated with nonme- 
tabolizable materials exhibit comparatively long term production of collagenase 
(18) and plasminogen activator (19) imply that the pristane granuloma may be a 
rich source of soluble, macrophage-elaborated products. 
Further, insoluble materials deposited by macrophages may be instrumental 
in the conditioning process. Culp et al.  (20-22)  report that substrate-attached 
materials produced by fibroblasts in vitro provide a substratum for subsequent 
cellular attachment and proliferation. 
Although the bulk of  the free peritoneal cell increase aider pristane injection is 
due to macrophages, the PMNL also increase in number and are present in the 
granuloma. Further, PMNL may comprise as much as 49% of the APC popula- 
tion obtained from pristane-treated mice. Therefore, the possibility that PMNL 
may play a  role in the conditioning process cannot be disregarded. Evidence 
exists that certain functional characteristics are shared by macrophages and 
PMNL. These include the production of neutral proteases (23), the presence of 
surface receptors for C3 and immunoglobulin (24), and the enhancement of T- 
lymphocyte mitogenic responses to phytohemagglutinin (25). The possible partic- 
ipation of PMNL in the conditioning effect thus warrants further investigation. 
The APCs might also provide an immune protection mechanism by altering or 
masking PCT cell surface antigens or by altering the host's immune system 
either generally or locally. Pristane conditioning apparently abrogates estab- 
lished immunity to the PCT AdjPC 5, permitting tumor growth (26). Recently, 
Ptak and Gershon (27) have shown that the in vitro plaque-forming response to 
sheep erythrocytes is  suppressed by peritoneal macrophages or macrophage 
membranes when they are added during the initial stimulation of the lympho- MICHAEL  CANCRO  AND  MICHAEL  POTTER  1565 
cyte cultures. Further, Broder et ah (28) reported that the mononuclear cells of 
myeloma patients actively suppress immunoglobulin synthesis by B  lympho- 
cytes from normal individuals. 
It  is  likely  that  the  pristane-induced  APC  granuloma  exerts  its  effects 
through a combination of activities which ultimately result in the production of 
a unique environment. This environment is a necessary prerequisite for success- 
ful primary PCT growth and is probably a  critical factor in the emergence of 
primary neoplastic plasma cell clones. 
The exclusive or greatly enhanced growth of developing neoplastic PCT clones 
in a  particular microenvironment suggests the emerging clone is dependent 
upon extrinsic factors for its growth. This microenvironmental growth depend- 
ence closely resembles hormone dependent growth observed in other systems 
(29).  Although primary PCT cells are  aberrant  with respect to proliferative 
control, conditioning dependence implies that their response to certain regula- 
tory  constraints  is  still  operational.  Based  upon these  considerations,  it  is 
tempting to speculate on the implications of the pristane-conditioning effect 
regarding both plasmacytomagenesis and the regulation of normal plasma cell 
proliferation. 
Completely autonomous cellular proliferation requires that the normal regu- 
latory mechanisms influencing division be lost or rendered ineffective. This is 
only partially true of primary PCTs, suggesting that at least two regulatory 
constraints are normally active in this system. The appearance of a  primary 
PCT might reflect the loss of responsiveness to only one of these constraints. 
Such a  preneoplastic clone, however, would not proliferate except when pro- 
vided with the necessary secondary stimulus such as the physical interaction 
with a  suitable substratum.  The pristane-induced oil granuloma would thus 
provide a selective microenvironment  for the preneoplastic clones by prOviding a 
continual source of this stimulation. 
Summary 
The intraperitoneal injection of pristane (2,6,10,14-tetramethylpentadecane) 
produces an environment conducive to primary plasmacytoma growth in as few 
as  3  days.  Aider pristane  injection,  the  total  free peritoneal cell population 
increases from a normal value of 1.55  ×  106 to 5.28  ×  l0  s and remains at this 
elevated level for at least 50 days.  The adherent peritoneal cell population, 
composed of both mononuclear cells and polymorphonuclear leukocytes, is the 
primary source of this increase. In the pristane-conditioned peritoneum, these 
cells rapidly form a  chronic granuloma on the peritoneal connective tissues. 
Daily subcutaneous treatment of mice with 0.5 mg of hydrocortisone beginning 
simultaneously with pristane injection prevents the increase in the peritoneal 
cell  population,  granuloma  formation,  and  the  production of a  conditioned 
environment. In mice treated with hydrocortisone beginning 3 days after pris- 
tane injection, however, neither the peritoneal cell increase nor the production 
of a  conditioned environment is  prevented.  The  intraperitoneal  injection of 
thioglycolate medium at  4-day  intervals  produces  an  elevation of the  free 
adherent peritoneal cell population similar to pristane, but does not produce a 
granuloma or a conditioned environment. The intraperitoneal transfer of thio- 1566  ATTACHED  MACROPHAGES  PROMOTE  PLASMACYTOMA  GROWTH 
glycolate-induced adherent peritoneal cells to mice treated with pristane and 
hydrocortisone simultaneously restores the production of a conditioned environ- 
ment. These findings indicate that the adherent peritoneal cell population is 
responsible for the conditioning effect, and that the establishment of a resident 
population of these cells is necessary to produce conditioning. 
Received for publication 16 August 1976. 
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